As pharmacists we have proven repeatedly, especially during the pandemic, that we do not walk away from a challenge, especially when it has the potential to vastly improve patient care.
Either amoxicillin or amoxicillin-clavulanate will clear infection, but the former is less likely to result in side-effects or antimicrobial resistance.
Updated practice parameter evaluates current evidence and provides guidance to healthcare practitioners on the diagnosis and management of anaphylaxis.